Iron Deficiency Anemias Clinical Trial
Official title:
The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.
In total 50 subjects with iron deficiency anemia treated with intravenous iron are planned
for inclusion in this trial. After signing an informed consent a blood sample will be
obtained from each participant before iron treatment. The investigators will measure the
thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). patient
will go face to face interview and will be asked to answer structured questionnaire which
will include information on demographics, clinical data ( fever, allergies , etc.) and
comorbidities
Two weeks after completing intravenous iron administration additional blood samples will be
taken: thrombin generation will be measured
n/a